XIAOMI-W
01810
BEKE-W
02423
MEITUAN-W
03690
4
NTES-S
09999
5
BOSS ZHIPIN-W
02076
HK Stock MarketDetailed Quotes
02196 FOSUN PHARMA
- 15.700
- 0.0000.00%
Market Closed Apr 3 16:08 CST
41.80BMarket Cap13.97P/E (TTM)
15.880High15.340Low5.67MVolume15.520Open15.700Pre Close88.32MTurnover1.04%Turnover Ratio13.97P/E (Static)2.66BShares19.50052wk High0.82P/B8.52BFloat Cap11.02052wk Low0.30Dividend TTM542.73MShs Float80.580Historical High0.301Dividend LFY3.44%Amplitude5.897Historical Low15.589Avg Price500Lot Size1.92%Div YieldTTM1.92%Div Yield LFY
FOSUN PHARMA Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -0.82%40.91B | 0.69%30.91B | -4.38%20.38B | -6.56%10.16B | -5.85%41.25B | -2.92%30.7B | 0.19%21.32B | 4.68%10.87B | 12.73%43.81B | 16.91%31.62B |
| Operating income | -0.82%40.91B | 0.69%30.91B | -4.38%20.38B | -6.56%10.16B | -5.85%41.25B | -2.92%30.7B | 0.19%21.32B | 4.68%10.87B | 12.73%43.81B | 16.91%31.62B |
| Cost of sales | 1.06%-21.37B | ---- | 2.20%-10.46B | ---- | 6.80%-21.6B | ---- | 7.58%-10.7B | ---- | -14.53%-23.17B | ---- |
| Operating expenses | 1.06%-21.37B | -0.70%-15.89B | 2.20%-10.46B | 4.10%-5.08B | 6.80%-21.6B | 6.70%-15.78B | 7.58%-10.7B | 9.67%-5.29B | -14.53%-23.17B | -24.03%-16.91B |
| Gross profit | -0.55%19.54B | 0.68%15.02B | -6.57%9.92B | -8.90%5.08B | -4.79%19.65B | 1.43%14.92B | 9.47%10.62B | 23.28%5.58B | 10.77%20.64B | 9.68%14.71B |
| Selling expenses | 10.63%-8.68B | 8.78%-6.59B | 15.87%-4.27B | 10.93%-2.24B | -5.90%-9.71B | -11.23%-7.23B | -21.72%-5.07B | -21.59%-2.52B | -0.77%-9.17B | 0.94%-6.5B |
| Administrative expenses | 1.23%-4.44B | 0.77%-3.14B | -2.17%-2.15B | -1.13%-1B | -14.80%-4.5B | -20.61%-3.17B | -22.62%-2.1B | -25.25%-991.09M | -18.15%-3.92B | -16.73%-2.63B |
| Research and development expenses | 16.15%-3.64B | 16.07%-2.65B | 12.77%-1.86B | 14.38%-829.57M | -1.02%-4.35B | -10.22%-3.16B | -17.38%-2.13B | -19.66%-968.87M | -12.11%-4.3B | -18.60%-2.86B |
| Profit from asset sales | ---- | -60.10%2.51M | ---- | 185.51%434.1K | ---- | -95.50%6.3M | ---- | -173.65%-507.68K | ---- | 2,026.44%140.1M |
| Revaluation surplus | ---- | -113.18%-106.25M | ---- | 86.36%-20.14M | ---- | 141.76%806.34M | ---- | 89.13%-147.61M | ---- | -245.96%-1.93B |
| -Changes in the fair value of other assets | ---- | -113.18%-106.25M | ---- | 86.36%-20.14M | ---- | 141.76%806.34M | ---- | 89.13%-147.61M | ---- | -245.96%-1.93B |
| Impairment and provision | 16.14%-110.63M | 74.38%-95.41M | 34.39%-38.04M | 58.87%-10.53M | -101.82%-131.93M | -189.88%-372.49M | -153.61%-57.98M | -328.87%-25.6M | 11.68%-65.37M | 51.81%-128.49M |
| -Other impairment is provision | 16.14%-110.63M | 74.38%-95.41M | 34.39%-38.04M | 58.87%-10.53M | -101.82%-131.93M | -189.88%-372.49M | -153.61%-57.98M | -328.87%-25.6M | 11.68%-65.37M | 51.81%-128.49M |
| Operating interest expense | ---- | ---- | -17.60%-709.55M | ---- | ---- | ---- | ---603.38M | ---- | ---- | ---- |
| Special items of operating profit | -15.74%914.58M | -29.30%1.76B | -80.38%194.7M | -49.69%416.77M | 353.64%1.09B | -24.67%2.49B | 1,392.87%992.21M | -46.80%828.41M | -91.36%239.26M | 62.78%3.3B |
| Operating profit | 74.56%3.58B | -3.32%3.96B | -33.52%1.09B | -22.91%1.3B | -40.08%2.05B | 4.02%4.1B | -13.69%1.64B | 70.06%1.69B | -19.44%3.43B | -22.64%3.94B |
| Financing income | 2.63%373.21M | ---- | ---- | ---- | 28.66%363.65M | ---- | ---- | ---- | --282.64M | ---- |
| Financing cost | -8.08%-1.43B | -13.03%-854.56M | ---- | -7.26%-280.22M | -37.46%-1.32B | -99.46%-756.08M | ---- | -144.12%-261.26M | ---963.81M | 3.66%-379.07M |
| Share of profits of associates | -23.40%1.83B | ---- | -15.29%947.2M | ---- | 15.36%2.39B | ---- | 24.43%1.12B | ---- | 1.60%2.07B | ---- |
| Share of profit from joint venture company | 8.72%-184.41M | ---- | -10.47%-105.88M | ---- | 13.63%-202.03M | ---- | 3.74%-95.84M | ---- | 5.44%-233.93M | ---- |
| Adjustment items of earning before tax | ---- | 27.58%-36.02M | ---- | 93.06%-2.94M | ---- | 73.78%-49.74M | ---- | -410.57%-42.38M | ---- | -474.73%-189.71M |
| Earning before tax | 27.23%4.17B | -6.71%3.07B | -27.44%1.93B | -26.46%1.02B | -28.46%3.28B | -2.33%3.29B | 11.90%2.66B | 57.80%1.38B | -24.20%4.58B | -27.76%3.37B |
| Tax | -77.76%-656.84M | 13.40%-553.05M | 37.49%-381.47M | 14.16%-232.2M | 41.06%-369.5M | -4.43%-638.65M | -19.87%-610.25M | -11.16%-270.51M | 41.21%-626.92M | 16.37%-611.54M |
| After-tax profit from continuing operations | 20.81%3.51B | -5.10%2.52B | -24.45%1.55B | -29.44%786.22M | -26.46%2.91B | -3.83%2.65B | 9.73%2.05B | 75.70%1.11B | -20.55%3.95B | -29.87%2.76B |
| Earning after tax | 20.81%3.51B | -5.10%2.52B | -24.45%1.55B | -29.44%786.22M | -26.46%2.91B | -3.83%2.65B | 9.73%2.05B | 75.70%1.11B | -20.55%3.95B | -29.87%2.76B |
| Minority profit | 45.94%742.55M | 36.99%507.88M | 21.36%324.93M | 38.66%176.49M | 134.84%508.8M | 14.66%370.74M | -15.27%267.75M | -28.33%127.28M | -12.48%216.66M | -12.66%323.34M |
| Profit attributable to shareholders | 15.48%2.77B | -11.93%2.01B | -31.33%1.22B | -38.22%609.73M | -35.81%2.4B | -6.29%2.28B | 14.81%1.78B | 116.17%986.97M | -20.97%3.74B | -31.66%2.44B |
| Basic earnings per share | 15.56%1.04 | -12.79%0.75 | -31.34%0.46 | -37.84%0.23 | -37.06%0.9 | -8.51%0.86 | 11.67%0.67 | 105.56%0.37 | -22.70%1.43 | -32.37%0.94 |
| Diluted earnings per share | 15.56%1.04 | -11.76%0.75 | -31.34%0.46 | -37.84%0.23 | -37.06%0.9 | -9.57%0.85 | 11.67%0.67 | 105.56%0.37 | -22.70%1.43 | -32.37%0.94 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- |
| Auditor | -- | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
HK Tech and Internet Stocks HK Tech and Internet Stocks
Stocks of companies primarily involved in technology and internet sectors in the HK stock market.Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in HK Tech and Internet Stocks, ranked from highest to lowest based on real-time market data. Stocks of companies primarily involved in technology and internet sectors in the HK stock market.Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in HK Tech and Internet Stocks, ranked from highest to lowest based on real-time market data.
Unlock Now